Skip to main content
. 2024 Sep 15;16(9):4450–4465. doi: 10.62347/QRIF7244

Figure 4.

Figure 4

Immunohistochemical staining of BRCA1, BRCA2, and TP53 in pathogenic vs. non-pathogenic prostate cancer samples. A. Immunohistochemical staining results for BRCA1 between samples with and without pathogenic mutations. B. Immunohistochemical staining results for BRCA2 between samples with and without pathogenic mutations. C. Immunohistochemical staining results for TP53 between samples with and without pathogenic mutations.